Lab901

Agilent Technologies has launched Genomic DNA ScreenTape, a prepackaged consumables device that works with the company’s 2200 TapeStation instrument to determine the quantity, size and quality of genomic DNA in less than two minutes per sample, using one microlit

Lab901's automated benchtop gel electrophoresis system and associated consumables are expected to complement Agilent's existing commercial offerings for gel electrophoresis. Lab901 also has a fledgling multiplex PCR-based diagnostic business that Agilent will review in coming weeks.

While Agilent said the purchase would "address customer needs across the entire span of electrophoresis life-science applications," Lab901 also provides applications for array users.

"With this technology and the team that developed it now part of Agilent, we can expand our reach in the pharmaceutical and clinical mass spec markets," an Agilent official said of the Biocius purchase.

Some microarray firms, such as Oxford Gene Technology, have adopted Lab901's ScreenTape for RNA quality control purposes.

John Anson, R&D director at OGT, said that the UK company adopted Lab901's system to improve the quality of its services business.

Lab901 will optimize its ScreenTape PCR diagnostics platform for use with Biofortuna’s multiplex PCR diagnostics kits for the detection of celiac disease and other HLA-related disease such as reactive arthritis, diabetes, and drug hypersensitivity.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.